Cargando…
Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma
Lung adenocarcinoma (LUAD) is the most common and deadliest subtype of lung cancer. To select more targeted and effective treatments for individuals, further advances in classifying LUAD are urgently needed. The number, type, and function of T cells in the tumor microenvironment (TME) determine the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tech Science Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513944/ https://www.ncbi.nlm.nih.gov/pubmed/37744265 http://dx.doi.org/10.32604/or.2023.042309 |
_version_ | 1785108625965973504 |
---|---|
author | SUN, LU TAN, HUAICHENG YU, TING LIANG, RUICHAO |
author_facet | SUN, LU TAN, HUAICHENG YU, TING LIANG, RUICHAO |
author_sort | SUN, LU |
collection | PubMed |
description | Lung adenocarcinoma (LUAD) is the most common and deadliest subtype of lung cancer. To select more targeted and effective treatments for individuals, further advances in classifying LUAD are urgently needed. The number, type, and function of T cells in the tumor microenvironment (TME) determine the progression and treatment response of LUAD. Long noncoding RNAs (lncRNAs), may regulate T cell differentiation, development, and activation. Thus, our aim was to identify T cell-related lncRNAs (T cell-Lncs) in LUAD and to investigate whether T cell-Lncs could serve as potential stratifiers and therapeutic targets. Seven T cell-Lncs were identified to further establish the T cell-related lncRNA risk score (TRS) in LUAD. Low TRS individuals were characterized by robust immune status, fewer genomic alterations, and remarkably longer survival than high TRS individuals. The excellent accuracy of TRS in predicting overall survival (OS) was validated in the TCGA-LUAD training cohort and the GEO-LUAD validation cohort. Our data demonstrated the favorable predictive power of the TRS-based nomogram, which had important clinical significance in estimating the survival probability for individuals. In addition, individuals with low TRS could respond better to chemotherapy and immunotherapy than those with high TRS. LINC00525 was identified as a valuable study target, and the ability of LUAD to proliferate or invade was significantly attenuated by downregulation of LINC00525. In conclusion, the TRS established by T cell-Lncs could unambiguously classify LUAD patients, predict their prognosis and guide their management. Moreover, our identified T cell-Lncs could provide potential therapeutic targets for LUAD. |
format | Online Article Text |
id | pubmed-10513944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Tech Science Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-105139442023-09-23 Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma SUN, LU TAN, HUAICHENG YU, TING LIANG, RUICHAO Oncol Res Article Lung adenocarcinoma (LUAD) is the most common and deadliest subtype of lung cancer. To select more targeted and effective treatments for individuals, further advances in classifying LUAD are urgently needed. The number, type, and function of T cells in the tumor microenvironment (TME) determine the progression and treatment response of LUAD. Long noncoding RNAs (lncRNAs), may regulate T cell differentiation, development, and activation. Thus, our aim was to identify T cell-related lncRNAs (T cell-Lncs) in LUAD and to investigate whether T cell-Lncs could serve as potential stratifiers and therapeutic targets. Seven T cell-Lncs were identified to further establish the T cell-related lncRNA risk score (TRS) in LUAD. Low TRS individuals were characterized by robust immune status, fewer genomic alterations, and remarkably longer survival than high TRS individuals. The excellent accuracy of TRS in predicting overall survival (OS) was validated in the TCGA-LUAD training cohort and the GEO-LUAD validation cohort. Our data demonstrated the favorable predictive power of the TRS-based nomogram, which had important clinical significance in estimating the survival probability for individuals. In addition, individuals with low TRS could respond better to chemotherapy and immunotherapy than those with high TRS. LINC00525 was identified as a valuable study target, and the ability of LUAD to proliferate or invade was significantly attenuated by downregulation of LINC00525. In conclusion, the TRS established by T cell-Lncs could unambiguously classify LUAD patients, predict their prognosis and guide their management. Moreover, our identified T cell-Lncs could provide potential therapeutic targets for LUAD. Tech Science Press 2023-09-15 /pmc/articles/PMC10513944/ /pubmed/37744265 http://dx.doi.org/10.32604/or.2023.042309 Text en © 2023 Sun et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article SUN, LU TAN, HUAICHENG YU, TING LIANG, RUICHAO Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma |
title | Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma |
title_full | Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma |
title_fullStr | Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma |
title_full_unstemmed | Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma |
title_short | Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma |
title_sort | identification of lncrnas associated with t cells as potential biomarkers and therapeutic targets in lung adenocarcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513944/ https://www.ncbi.nlm.nih.gov/pubmed/37744265 http://dx.doi.org/10.32604/or.2023.042309 |
work_keys_str_mv | AT sunlu identificationoflncrnasassociatedwithtcellsaspotentialbiomarkersandtherapeutictargetsinlungadenocarcinoma AT tanhuaicheng identificationoflncrnasassociatedwithtcellsaspotentialbiomarkersandtherapeutictargetsinlungadenocarcinoma AT yuting identificationoflncrnasassociatedwithtcellsaspotentialbiomarkersandtherapeutictargetsinlungadenocarcinoma AT liangruichao identificationoflncrnasassociatedwithtcellsaspotentialbiomarkersandtherapeutictargetsinlungadenocarcinoma |